SEC Filings - Vivos, Inc.
trading symbol: OTCQB: RDGL
Vivos Form 10-K December 31, 2022
Vivos Inc. – December 31, 2022 Annual Report
Home Page Cover Image:
Veterinarian Dr. Michelle Myer from Vista Veterinarian Hospital in Kennewick, WA.
Seen here administering IsoPet® therapy to a feline suffering from a sarcoma.
RadioGel™ is a hydrogel liquid containing tiny yttrium-90 (90Y) phosphate particles that may be administered directly into a tumor. The hydrogel is an yttrium-90 carrier at room temperature that gels within the tumor interstitial spaces after injection to keep the radiation sources safely in place. The short-range beta radiation from yttrium-90 localizes the dose within the treatment area so that normal organs and tissues are not adversely affected.
IsoPet® Therapy Application(s)
Precision Radionuclide Therapy (PRnT)
Vivos Inc. - (OTCQB: RDGL) Investor Relations
Contact
Main colors
| bg-primary | |
| bg-primary-light | |
| bg-primary-dark | |
| bg-secondary | |
| bg-secondary-dark |
Template sections
| body | |
| top-header | |
| header | |
| content |
Footer Styles
| background | |
| text color | |
| link color | |
| horizontal line |
Buttons
| style 1 | |
| style 2 | |
| style 3 |
Other elements
| social icons | |
| navigation color | |
| subnav background |
Mobile navigation
| background color | |
| navigation color |
Template configurations
has-right-nav g-font
navigation styles
size-15 weight-400 snip-nav
content styles
form-white
footer styles
o-form color-white
Typography
Heading H1
weight-600
Heading H2
weight-600
Heading H3
weight-600
Buttons
weight-600 is-uppercase
Animations
Note: All changes made here will be applied to your entire website.
is-switcher admin-only
Precision Radionuclide Therapy (PRnT)
draggable-logo